Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies

S. Ashwin Reddy; Joseph Newman; Olivia C. Leavy; Hakim Ghani; Joanna Pepke‐Żaba; John Cannon; Karen Sheares; Dolores Taboada; Katherine Bunclark; Allan Lawrie; Cathie Sudlow; Colin Berry; Jim M. Wild; Jane A. Mitchell; Jennifer K Quint; Jennifer Rossdale; Laura Price; Luke Howard; Martin R. Wilkins; Naveed Sattar; Phil Chowienczyk; A. A. Roger Thompson; Louise V. Wain; Alex Horsley; Ling‐Pei Ho; James D. Chalmers; Michael Marks; Krisnah Poinasamy; Betty Raman; Victoria Harris; Linzy Houchen-Wolloff; Christopher E. Brightling; Rachael A. Evans; Mark Toshner

doi:10.1183/13993003.01742-2023

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Pulmonary embolism (PE) is a well-recognised complication of coronavirus disease 2019 (COVID-19) infection, and chronic thromboembolic pulmonary disease with and without pulmonary hypertension (CTEPD/CTEPH) are potential life-limiting consequences. At present the burden of CTEPD/CTEPH is unclear and optimal and cost-effective screening strategies yet to be established.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Reddy et al. (2024) studied this question.

synapsesocial.com/papers/68e5ee7cb6db643587582d35 https://doi.org/10.1183/13993003.01742-2023

View Full Paper

Ask AI

Bookmark

Share

Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies

Ask about this paper

Abstract

Discussion

Cite This Study

Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading